Royal Dutch Shell faced an investor revolt at its annual meeting on Tuesday when just under half of voting shareholders failed to back a plan to award three executives €1m (£795,000) bonuses to stay in their jobs.

The pay protest at the meeting in The Hague was one of the most significant for a UK company since GlaxoSmithKline’s investors rejected the healthcare group’s controversial pay policies for senior executives in 2003.